Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren M Hook

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Protocols|December 22, 2021
Guinea Pig and Mouse Models for Genital Herpes InfectionLauren M Hook, Harvey M Friedman, Sita Awasthi
Human Vaccines & Immunotherapeutics|May 9, 2017
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection modelSita Awasthi, Lauren M Hook, Carolyn E Shaw, et al.
Mbio|March 9, 2017
Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβMeaghan H Hancock, Lauren M Hook, Jennifer Mitchell, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 19, 2014
Techniques for characterizing cytomegalovirus-encoded miRNAsLauren M Hook, Igor Landais, Meaghan H Hancock, et al.
Human Vaccines & Immunotherapeutics|April 30, 2020
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infectionKevin Egan, Lauren M Hook, Alexis Naughton, et al.
Journal of Virology|May 16, 2008
Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and ELauren M Hook, Jialing Huang, Ming Jiang, et al.
Journal of Virology|March 31, 2006
Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibodyLauren M Hook, John M Lubinski, Ming Jiang, et al.
Vaccine|December 16, 2018
A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infectionLauren M Hook, Sita Awasthi, Jonathan Dubin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 10, 2020
Vaccines to prevent genital herpesKevin Egan, Lauren M Hook, Philip LaTourette, et al.
Journal of Virology|September 16, 2004
Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytesPrakash K Bhuyan, Katalin Karikò, John Capodici, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Protocols|December 22, 2021
Guinea Pig and Mouse Models for Genital Herpes InfectionLauren M Hook, Harvey M Friedman, Sita Awasthi
Human Vaccines & Immunotherapeutics|May 9, 2017
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection modelSita Awasthi, Lauren M Hook, Carolyn E Shaw, et al.
Mbio|March 9, 2017
Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβMeaghan H Hancock, Lauren M Hook, Jennifer Mitchell, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 19, 2014
Techniques for characterizing cytomegalovirus-encoded miRNAsLauren M Hook, Igor Landais, Meaghan H Hancock, et al.
Human Vaccines & Immunotherapeutics|April 30, 2020
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infectionKevin Egan, Lauren M Hook, Alexis Naughton, et al.
Journal of Virology|May 16, 2008
Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and ELauren M Hook, Jialing Huang, Ming Jiang, et al.
Journal of Virology|March 31, 2006
Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibodyLauren M Hook, John M Lubinski, Ming Jiang, et al.
Vaccine|December 16, 2018
A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infectionLauren M Hook, Sita Awasthi, Jonathan Dubin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 10, 2020
Vaccines to prevent genital herpesKevin Egan, Lauren M Hook, Philip LaTourette, et al.
Journal of Virology|September 16, 2004
Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytesPrakash K Bhuyan, Katalin Karikò, John Capodici, et al.
Pageof 3